Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

Averna Maurizio; Banach Maciej; Bruckert Eric; Drexel Heinz; Farnier Michel; Gaita Dan; Magni Paolo; Maerz Winfried; Masana Luis; Mello e Silva Alberto; Reiner Zeljko; Ros Emilio; Vrablik Michal; Zambon Alberto; Zamorano Jose L.; Stock Jane K.; Tokgozoglu Lale S.; Catapano Alberico L.

首页> 外文期刊>Atherosclerosis >Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

【24h】

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

机译：高高风险患者组合脂质改性治疗的实用指导：欧洲动脉粥样硬化协会工作队的一份声明

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and aims: This European Atherosclerosis Society (EAS) Task Force provides practical guidance for combination therapy for elevated low-density lipoprotein cholesterol (LDL-C) and/or triglycerides (TG) in highrisk and very-high-risk patients.

机译：None

著录项

来源
《Atherosclerosis 》 |2021年第1期| 共11页
作者
Averna Maurizio; Banach Maciej; Bruckert Eric; Drexel Heinz; Farnier Michel; Gaita Dan; Magni Paolo; Maerz Winfried; Masana Luis; Mello e Silva Alberto; Reiner Zeljko; Ros Emilio; Vrablik Michal; Zambon Alberto; Zamorano Jose L.; Stock Jane K.; Tokgozoglu Lale S.; Catapano Alberico L.;
展开▼
作者单位

Univ Palermo Dept Hlth Promot Sci Maternal &

Infantile Care Internal Med &

Med Special Palermo;

Polish Mothers Mem Hosp Res Inst PMMHRI Lodz Lodz Poland;

Hop La Pitie Salpetriere Paris France;

Vorarlberg Inst Vasc Invest &

Treatment VIVIT Feldkirch Austria;

Univ Bourgogne Franche Comte EA 7460 PEC2 Dijon France;

Univ Med Si Farm Victor Babes Inst Boli Cardiovasc Clin Recuperare Cardiovasc Timisoara Romania;

Univ Milan Dept Pharmacol &

Biomol Sci Milan Italy;

SYNLAB Holding Deutschland GmbH SYNLAB Acad Heidelberg Germany;

Univ Rovira &

Virgili Vasc Med &

Metab Unit Res Unit Lipids &

Atherosclerosis IISPV CIBERDEM St;

Luz Saude Portugal Lisbon Portugal;

Zagreb Univ Dept Internal Dis Sch Med Univ Hosp Ctr Zagreb Zagreb Croatia;

Hosp Clin Barcelona Inst Invest Biomed August Pi &

Sunyer IDIBAPS Endocrinol &

Nutr Serv Lipid;

Charles Univ Prague Gen Univ Hosp Dept Internal Med 3 U Nemocnice 1 Prague 12808 2 Czech;

IRCCS MultiMed Milan Italy;

Univ Hosp Ramon Y Cajal Dept Cardiol Carretera Colmenar Madrid Spain;

European Atherosclerosis Soc Massans Gata 10 SE-41251 Gothenburg Sweden;

Hacettepe Univ Dept Cardiol Fac Med Ankara Turkey;

Univ Milan Dept Pharmacol &

Biomol Sci Milan Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病 ;
关键词
2019 ESC; EAS Dyslipidaemia Guidelines; Combination treatment; LDL cholesterol; Triglycerides; Lipid goals; High-risk;

机译：2019 ESC;EAS腹腔膜血症指南;联合治疗;LDL胆固醇;甘油三酯;脂质目标;高风险;

相似文献

外文文献
中文文献
专利

1. European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk [J] . Landmesser Ulf, Chapman M. John, Farnier Michel, European Heart Journal: The Journal of the European Society of Cardiology . 2017 ,第29期

机译：欧洲心脏病学会/欧洲动脉粥样硬化协会关于普罗基蛋白转化酶枯草杆菌蛋白酶/ kexin型9型抑制剂的共识陈述：在非常高的心血管风险下使用患者的实际指导
2. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP) [J] . Alexis Tabah, Matteo Bassetti, Marin H. Kollef, Intensive care medicine . 2020 ,第2期

机译：患者患者的抗菌脱升升级：来自欧洲重症监护医学学会（ESICM）和欧洲临床微生物学和传染病学会（ESCMID）危重病人研究组（ESGCIP）的职位声明
3. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement [J] . Hegele Robert A., Boren Jan, Ginsberg Henry N., The lancet. Diabetes & endocrinology. . 2020 ,第1期

机译：罕见的腹膜脂血症，从表型到基因型到管理：欧洲动脉粥样硬化协会工作组共识声明
4. COVID-19: Interim Guidance on Rehabilitation in the Hospital and Post-Hospital Phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force [O] . Martijn A. Spruit, Anne E. Holland, Sally J. Singh, -1

机译：Covid-19：欧洲呼吸社会和美国胸部社会协调的国际工作队中医院康复和医院后阶段的临时指南
5. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:XX-XX.33This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (www.americanheart.org), the European Society of Cardiology (www.escardio.org), and the North American Society of Pacing and Electrophysiology (www.naspe.org). Single reprints of this document (the complete Guidelines) to be published in the mid-October issue of the European Heart Journal are available by calling +44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines – Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. Single reprints of the shorter version (Executive Summary and Summary of Recommendations) published in the October issue of the Journal of the American College of Cardiology and the October issue of Circulation, are available for $5.00 each by calling 800-253-4636 (US only) or by writing the Resource Center, American College of Cardiology, 9111 Old Georgetown Road, Bethesda, Maryland 20814. To purchase bulk reprints specify version and reprint number (Executive Summary 71-0208; full text 71-0209) up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology [O] . Fuster Valentin, Rydén Lars E., Asinger Richard W., 2001

机译：ACC / AHA / ESC治疗房颤患者指南31该文件于2001年8月获得美国心脏病学会董事会，2001年8月美国心脏协会科学咨询与协调委员会以及欧洲心脏病学会的批准以及实践指南和政策委员会会议（2001年8月）。32引用本文件时，美国心脏病学会，美国心脏协会和欧洲心脏病学会将赞赏以下引用格式：Fuster V，RydénLE，Asinger RW，Cannom DS，Crijns HJ，Frye RL，Halperin JL，Kay GN，Klein WW，LévyS，McNamara RL，Prystowsky EN，Wann LS，Wyse DG。 ACC / AHA / ESC治疗房颤患者的指南：美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南委员会和政策会议的报告（制定指南委员会）用于房颤患者的治疗）。 J Am Coll Cardiol 2001; 38：XX-XX.33本文件可在美国心脏病学会（www.acc.org），美国心脏协会（www.americanheart.org），欧洲的万维网站点上找到心脏病学会（www.escardio.org）和北美起搏和电生理学会（www.naspe.org）。可致电+44.207.424.4200或+44.207.424.4389，传真+44.207.424.4433或写信给Harcourt Publishers，以获取本文档（完整的准则）的单份重印本（完整的准则），该印刷本将于10月中旬出版。欧洲心脏杂志，ESC指南–转载，英国伦敦詹姆斯敦路32号，NW1 7BY。短版（执行摘要和建议摘要）的单版重印在《美国心脏病学会杂志》十月刊和《循环》十月刊上，致电800-253-4636（仅美国），每本售价5.00美元。）或写信给美国心脏病学院资源中心，地址是：马里兰州贝塞斯达市Old Georgetown Road 9111，邮编20814。要购买批量转载，请指定版本和转载编号（执行摘要71-0208；全文71-0209），最多999份，致电800-611-6083（仅限美国）或传真413-665-2671； 1000或更多副本，请致电214-706-1466，传真214-691-6342;或电子邮件：pubauth@heart.org。美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南和政策会议（制定房颤患者治疗指南委员会）的报告是与北方合作开发的美国起搏与电生理学会

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

摘要

著录项

相似文献

相关主题

期刊订阅